A Study to Test the Safety and Tolerability of Long-term UCB0107 Administration in Study Participants With Progressive Supranuclear Palsy
A Study to Test the Safety and Tolerability of Long-term UCB0107 Administration in Study Participants With Progressive Supranuclear Palsy
Active, not recruiting · NCT04658199 · Registry updated 2026-08-03Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Test the Safety and Tolerability of Long-term UCB0107 Administration in Study Participants With Progressive Supranuclear Palsy | Neurologic Manifestations, Ocular Motility Disorders, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, basal ganglia disorder, brain disorder, central nervous system disorder, cranial nerve neuropathy, eye disorder, movement disorder, nervous system disorder, neurodegenerative disease, ophthalmoplegia, palsy, progressive supranuclear palsy, tauopathy | Active, not recruiting | Phase 1 | 2026-08-03 | NCT04658199 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| UCB Biopharma SRL | 30 |
11 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Psp002 40002 | Leuven | Belgium | 1 |
| Psp002 40024 | Hanover | Germany | 1 |
| Psp002 40100 | Madrid | Spain | 1 |
| Psp002 40122 | Edegem | Belgium | 1 |
| Psp002 40165 | Southampton | United Kingdom | 1 |
| Psp002 40175 | London | United Kingdom | 1 |
| Psp002 40267 | Barcelona | Spain | 1 |
| Psp002 40268 | Pamplona | Spain | 1 |
| Psp002 40276 | Düsseldorf | Germany | 1 |
| Psp002 40277 | Bochum | Germany | 1 |
| Psp002 40278 | Essen | Germany | 1 |